Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 1996-02-04 (30 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: UZES (30700), Gard
PHARMACIE DES PORTES D' UZES : revenue, balance sheet and financial ratios
PHARMACIE DES PORTES D' UZES is a French company
founded 30 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in UZES (30700),
this company of category PME
shows in 2023 a revenue of 6.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES PORTES D' UZES (SIREN 409018066)
Indicator
2024
2023
2021
2020
2019
2018
2017
Revenue
N/C
6 489 973 €
5 568 099 €
4 683 853 €
4 010 651 €
3 027 211 €
2 734 432 €
Net income
484 166 €
519 771 €
517 341 €
267 427 €
333 505 €
178 833 €
213 704 €
EBITDA
N/C
736 804 €
776 004 €
532 021 €
535 500 €
315 274 €
312 051 €
Net margin
N/C
8.0%
9.3%
5.7%
8.3%
5.9%
7.8%
Revenue and income statement
In 2024, PHARMACIE DES PORTES D' UZES generates positive net income of 484 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 214 k€ -> 484 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
484 166 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 13%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 69%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
13.488%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
69.39%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES PORTES D' UZES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2023
2024
Debt ratio
5.031
31.265
29.36
21.875
32.125
18.639
13.488
Financial autonomy
80.394
63.227
64.494
67.034
61.913
70.03
69.39
Repayment capacity
0.391
2.226
1.352
1.25
1.15
0.977
None
Cash flow / Revenue
8.318%
8.115%
10.326%
7.36%
10.431%
8.74%
None%
Sector positioning
Debt ratio
13.492024
2021
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of PHARMACIE DES PORTES D' UZES (13.49) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
69.39%2024
2021
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good
In 2024, the financial autonomy of PHARMACIE DES PORTES D' UZES (69.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
0.98 years2023
2021
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Good
In 2023, the repayment capacity of PHARMACIE DES PORTES D' UZES (0.98) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 303.55. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
303.554
Liquidity indicators evolution PHARMACIE DES PORTES D' UZES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2023
2024
Liquidity ratio
201.31
179.412
221.625
214.797
250.371
340.914
303.554
Interest coverage
0.155
0.737
0.324
0.498
0.286
0.237
None
Sector positioning
Liquidity ratio
303.552024
2021
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent
In 2024, the liquidity ratio of PHARMACIE DES PORTES D' UZES (303.55) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
0.24x2023
2021
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of PHARMACIE DES PORTES D' UZES (0.2x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DES PORTES D' UZES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2023
2024
Operating WCR
305 819 €
589 761 €
757 732 €
759 393 €
991 734 €
1 205 318 €
0 €
Inventory turnover (days)
41
60
59
51
50
52
0
Customer payment term (days)
0
0
0
0
0
3
0
Supplier payment term (days)
42
51
42
39
37
40
0
Positioning of PHARMACIE DES PORTES D' UZES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DES PORTES D' UZES is estimated at
6 759 315 €
(range 4 707 080€ - 10 112 322€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
4707k€6759k€10112k€
6 759 315 €Range: 4 707 080€ - 10 112 322€
NAF 5 année 2024
Valuation method used
Net Income Multiple
484 166 €
×
14.0x
=6 759 315 €
Range: 4 707 080€ - 10 112 322€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES PORTES D' UZES with other companies in the same sector:
Frequently asked questions about PHARMACIE DES PORTES D' UZES
What is the revenue of PHARMACIE DES PORTES D' UZES ?
The revenue of PHARMACIE DES PORTES D' UZES in 2023 is 6.5 M€.
Is PHARMACIE DES PORTES D' UZES profitable?
Yes, PHARMACIE DES PORTES D' UZES generated a net profit of 484 k€ in 2024.
Where is the headquarters of PHARMACIE DES PORTES D' UZES ?
The headquarters of PHARMACIE DES PORTES D' UZES is located in UZES (30700), in the department Gard.
Where to find the tax return of PHARMACIE DES PORTES D' UZES ?
The tax return of PHARMACIE DES PORTES D' UZES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES PORTES D' UZES operate?
PHARMACIE DES PORTES D' UZES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart